Nanostring and visiopharm announce collaboration to co-develop integrated workflows for geomx and atomx spatial biology solutions

Seattle--(business wire)-- #spatialbiology--nanostring technologies, inc. (nasdaq: nstg), a leading provider of life science tools for discovery and translational research, and visiopharm, a world leader in ai-driven digital pathology software, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies.
NSTG Ratings Summary
NSTG Quant Ranking